Contact Us BASE

Centella leaves beside liquid and powder extract samples with a cosmetic formulation beaker
Centella Asiatica Extract in Skincare: What Formulators and Buyers Should Verify

Centella Asiatica Extract in Skincare: What Formulators and Buyers Should Verify

A B2B guide to evaluating Centella asiatica extract by identity, marker profile, evidence, formulation behavior, specifications and supplier documentation.

Two raw-material samples can carry a Centella-related name and still deliver different inputs to a cosmetic batch. One may be a hydroglycolic extract made from stalks and leaves; another may be a dry leaf extract or a material standardized to selected triterpenes. Their carriers, plant solids, marker profile, color, preservation and formulation behavior need not match.

That is the practical limitation behind the popularity of cica. Centella asiatica extract has credible relevance in skincare, but the plant name alone cannot tell a formulator what is in the drum or let a buyer transfer the result of one published study to every commercial grade.

A useful evaluation therefore moves through four questions: What material is this? What does the evidence actually support? How will the grade behave in the target formula? Which documents and tests are required before approval?

The ingredient name identifies a source, not a complete grade

Centella asiatica is a plant in the Apiaceae family. Cica, gotu kola and tiger grass are common conversational or marketing names associated with it, but none functions as a raw-material specification.

The cosmetic ingredient family is broader than one extract. The Cosmetic Ingredient Review (CIR) final assessment separately lists Centella asiatica extract, flower/leaf/stem extract, leaf extract, leaf water, root extract and several callus-, leaf-cell- or meristem-culture-derived materials. CIR describes their primary cosmetic function as skin conditioning. Those names distinguish source materials or production concepts that should not be collapsed into one evidence category.

Even Centella Asiatica Extract does not define the commercial grade in full. CIR documents examples made through propylene-glycol/water extraction, ethanol extraction and preparation of dried extracts. It also describes glycerin-containing cell-culture material. A supplier’s trade product may therefore contain the named botanical ingredient plus a carrier, solvent or preservation system that must be declared in the full composition.

For procurement and formulation, the minimum identity question is not simply “Is this Centella?” It is:

  • Which botanical species and plant part were used?
  • How was the plant material processed and extracted?
  • Is the delivered ingredient a liquid, powder, concentrated fraction or cell-culture material?
  • What are the carrier, solvent, preservative and botanical-solids components?
  • Is the grade standardized to named marker compounds, or controlled primarily by physical and microbiological specifications?

Until those questions are answered, an INCI or trade name is a category label, not proof of equivalence.

Four triterpenes matter, but their profile is not automatic

Four pentacyclic triterpenes recur in Centella literature: asiaticoside, madecassoside, asiatic acid and madecassic acid. The first two are glycosides; the latter two are related aglycones. They are useful analytical targets because much of the mechanistic and standardization discussion around Centella focuses on them.

Their presence and ratio cannot be assumed. A study of raw materials from different plant parts, locations and harvest periods found substantial variation in the four triterpenes. Leaves contained the most among the plant parts tested, but location and month of harvest also changed the measured total. A separate extraction study showed that technique, solvent system and other process variables altered the amount and balance of triterpenes recovered under its experimental conditions.

These studies do not establish a universally superior source or extraction method for cosmetics. Their practical value is narrower: source and process can change composition, so a botanical name is not sufficient process control.

HPLC methods can separate and quantify individual glycosides and aglycones. If a grade is positioned as standardized, ask the supplier to replace phrases such as “triterpene-rich” with a testable statement:

  • named marker or markers;
  • analytical method and sample-preparation basis;
  • units and reporting basis, such as supplied material or dry matter;
  • specification range rather than one idealized result; and
  • the actual value on the lot CoA.

An assay verifies what its method measures. It does not demonstrate skin penetration, finished-formula stability or consumer efficacy. Likewise, a “total triterpenes” result is not automatically interchangeable with separate limits for asiaticoside, madecassoside, asiatic acid and madecassic acid.

Read the evidence in levels, not as one Centella claim

The Centella evidence base includes analytical chemistry, cell experiments, wounds and medicinal preparations, small cosmetic studies and multi-ingredient finished formulas. Those layers are related, but they answer different questions.

Human formulation studies support cautious hydration relevance

In a four-week study of 25 volunteers, researchers applied cream and hydrogel formulations containing 2.5% or 5% Centella extract to the forearms twice daily. The 5% formulations performed best among the tested groups for stratum-corneum hydration, transepidermal water loss (TEWL) and a methyl-nicotinate redness model. (Study record)

This result supports interest in Centella-containing hydration and comfort formulas. It does not establish 5% as a universal use level. The sample was small, the site was the forearm rather than the face, and the result belongs to the extract and vehicles used in that study.

Two multi-ingredient studies make the attribution problem clearer. A one-day study in 20 women reported improved hydration and TEWL after applying a fluid containing 1% hyaluronic acid, 5% glycerin and a Centella stem-cell extract. The design cannot separate the contribution of Centella from the humectants and vehicle, and the paper disclosed a commercial relationship. (Study record)

A 2025 prospective observational study followed users of a cream containing Centella leaf extract, ceramide NP and panthenol. Hydration, TEWL, redness-related measurements and self-reported discomfort improved over four weeks, but the study had no placebo group and tested a three-part active system rather than isolated Centella. (Study record)

For product development, the defensible conclusion is narrow: Centella can be considered within a hydration- and comfort-oriented formulation strategy, while performance and claims must be established for the complete formula.

Mechanisms and wrinkle literature require tighter boundaries

In cultured human dermal fibroblasts, asiaticoside has been associated with cell-cycle, gene-expression and collagen-production changes. (In-vitro record) This is biological plausibility, not proof that an unspecified botanical grade in a leave-on cosmetic will reach the same cells at a comparable exposure and reduce wrinkles.

The same boundary applies to wound and medicinal literature. Damaged tissue, pharmaceutical preparations and standardized triterpene fractions are not direct substitutes for intact facial skin, a cosmetic carrier and an ordinary use pattern. “Historically used for wounds” cannot be converted into a cosmetic wound-healing claim.

Clinical aging evidence also remains material-dependent. A systematic review identified five double-blind randomized trials involving 172 Asian women and reported possible improvement in lip or periocular wrinkle outcomes. The authors nevertheless noted weak reporting and a lack of Centella standardization that limited general application. A buyer should treat “clinically supported Centella” as an invitation to inspect the exact test material, not as a class-wide claim.

Study concentration is not a supplier use level

Four percentages are often confused in botanical-ingredient discussions:

  1. the percentage of plant-derived material or dry extract in the supplier grade;
  2. the percentage of a named marker in that grade;
  3. the percentage of the trade product added to a study or formulation; and
  4. the delivered amount of botanical solids or markers in the finished product.

They are not interchangeable. Adding 5% of a dilute hydroglycolic extract is chemically different from adding 5% of a dry or concentrated material. A study that reports only “Centella extract” may not provide enough composition detail to bridge the result to another grade.

Historical concentration-of-use information has a different purpose again. CIR used industry data to evaluate safety under reported practices; those figures are not formulation instructions and do not prove efficacy. A supplier’s recommended range is grade-specific guidance, but it still does not replace formula-level safety, stability or claims work.

The more defensible path is:

Current grade documentation → target delivered solids or markers → bench compatibility and stability → finished-product performance and safety assessment.

If the supplier cannot explain the basis of its use range—solubility, preservation, sensory impact, safety data, assay target or finished-formula testing—the number offers little technical guidance.

Translate the grade into formulation consequences

The material’s commercial composition determines what enters the vessel. A water/glycol extract may contribute solvent and preservative along with botanical material. A powder or concentrated fraction creates a different weighing, dissolution and dispersion task. These differences can affect process design even when the headline plant is identical.

Before bench work, obtain the complete supplied composition and the grade’s physical/chemical data. Depending on the material, useful fields can include appearance, color, odor, pH, density, dry matter, solubility or dispersibility, carrier ratio, preservative system and storage conditions. These are not decorative TDS fields:

  • Carrier and dry matter determine how much botanical material or marker the formulation actually receives.
  • Color and odor ranges influence the acceptable sensory window and the need for a botanical blank or reference standard.
  • pH and solubility information guide phase selection and the initial process, but the complete formula still needs compatibility testing.
  • Preservatives and microbial limits affect the raw material’s contribution to the finished product’s preservation challenge.
  • Storage and shelf life define how samples and production lots should be handled before use.

Do not infer a universal addition temperature, pH range or order of addition from Centella literature. Those instructions must come from the current grade documentation and be tested in the intended emulsion, gel, toner, serum or cleansing system.

At minimum, compare the supplier sample in the target base at the intended use level and at realistic upper/lower development conditions. Track appearance, odor, color, pH, viscosity or rheology, precipitation, phase stability and packaging interaction as relevant. Run the preservation, safety and claims tests required for the finished product and market. A clear supplier dossier reduces uncertainty; it does not perform those tests for you.

Build a specification around the risk you need to control

A specification earns its place when each limit is connected to identity, process consistency, safety or formulation performance. Copying a generic botanical template can leave the highest-risk variables uncontrolled.

Identity and composition

Request the accepted botanical name, plant part, country or region of origin where relevant, and a concise manufacturing or extraction description. Confirm the exact cosmetic ingredient declaration and full trade-name composition, including carriers, solvents and preservatives.

Where claims or batch consistency depend on triterpenes, define the marker compounds, method, units and acceptance range. Also clarify whether the result is reported on the supplied material, dry residue or another basis. If the grade is not marker-standardized, establish which identity or fingerprint tests support consistency.

Batch quality and contaminants

The specification and CoA should use matched parameter names, limits, units and test methods. Depending on the risk assessment and material form, the review may include:

  • appearance, color, odor and relevant physical properties;
  • dry matter or assay/fingerprint controls;
  • total aerobic and yeast/mold counts plus specified organisms where appropriate;
  • heavy metals, pesticide residues, residual solvents or other process-related contaminants when relevant;
  • manufacturing date, retest or expiry date, storage and packaging; and
  • lot identity and traceability to the controlled production site.

“Pass” without a method, limit or actual result offers little help when teams need to compare suppliers or investigate drift. A certificate also needs a verified legal entity, site, issuer, validity and scope; management-system certification is not proof that the ingredient delivers a skincare result.

Evidence and claim support

Ask whether cited studies used the supplied grade, a compositionally comparable material, an isolated compound or a finished formula. Record who conducted and funded each test, the comparator, dose, endpoint, sample and statistical plan where available.

The CIR assessment concluded that the reviewed ingredients were safe in the reported practices and concentrations when formulated to be non-sensitizing. That qualification matters: allergic contact dermatitis has been reported, although case reports cannot estimate incidence. (Case record) Finished-formula safety work should not be replaced by “natural” or “soothing” positioning.

Claim language also changes regulatory risk. In the United States, the FDA states that cosmetic claims must be truthful and not misleading, and that claims to treat/prevent disease or affect body structure/function can create drug intent. Hydration, skin conditioning, comfort and appearance claims still need suitable substantiation; eczema treatment, wound healing or an unqualified collagen-production promise is a different proposition.

Cosmetic ingredient samples, specification documents and formulation tests arranged for Centella grade evaluation
Grade approval connects a traceable sample and controlled documents with testing in the intended formula. Conceptual workflow.

Qualify the supplier and grade in five gates

An efficient qualification sequence reduces the chance that an inexpensive sample becomes an expensive reformulation.

  1. Define the target material profile. State product format, intended cosmetic role, carrier restrictions, target markers if any, destination markets, claim direction and commercial volume.
  2. Review the dossier before formulation. Compare the full composition, specification, representative CoA, TDS, SDS, safety information, traceability and relevant contaminant statements against the target profile.
  3. Check a representative sample. Confirm that the sample identity and lot documents match. Record its appearance and basic physical data instead of evaluating only the marketing name.
  4. Test the complete formula. Run compatibility, stability, packaging, microbiological, safety and claims-relevant work appropriate to the product. Investigate drift rather than masking it with fragrance, color or process changes.
  5. Approve the supply controls. Confirm production site, lot traceability, deviation handling, complaint process, shelf life at shipment, lead time and written change notification before commercial purchase.

For a wider supplier-qualification process, use Saiyuan’s guide to vetting B2B cosmetic raw-material suppliers. The same principle applies here: documentation narrows risk, while the buyer’s sample and formula data determine suitability.

How to approach a Centella sourcing brief with Saiyuan

No current Saiyuan Centella grade dossier was supplied for this article, so availability, composition, assay, recommended use, certifications and stock should not be assumed.

If you want Saiyuan to evaluate a sourcing request, send a defined brief rather than only the ingredient name. Include the desired material form, carrier restrictions, target market, product format, claim direction, marker requirements, documentation needs, sample quantity, expected commercial volume and development timeline. A useful proposal should identify the actual manufacturer and site, the full supplied composition, current specification and CoA, relevant quality/safety documents, commercial terms and any limits on technical support.

Saiyuan’s ingredient and OEM/ODM capability overview provides company context. Any proposed Centella grade should still pass the same evidence, specification and formula checks described above.

The approval condition is simple even when the chemistry is not: the identity in the dossier, the material in the sample and the behavior in the finished formula must agree. That is when Centella asiatica extract becomes a controlled cosmetic ingredient rather than a familiar botanical name.

References

Why I write this

About my business

Our company specialises in the production of a wide range of skincare ingredients, including bio-fermented products and active peptides. We also support brands in their growth.
Our services
We not only sell skincare ingredients produced in-house, but also assist international clients in sourcing high-quality products in China. If you have any requirements in this regard, please do not hesitate to contact us.
Contact Profile
Name
Leslie Wong
Brand Name
Saiyuan-BIOTECH
Country
China
Model
B2B
ODM
OEM

Leave a Reply

Your email address will not be published. Required fields are marked *

Get in touch with us
  • Address: No. 1 Tianyuan East Road, Huangpu District, Guangzhou City, Guangdong Province, China
  • WhatsApp: +86 15360041254